Work

Nitroxoline as an antimicrobial synergist reverses colistin resistance in multidrug-resistant Escherichia coli

Year: 2025
Type: article
Abstract: infections. In conclusion, NTX is identified as a promising colistin adjuvant for the treatment of colistin-resistant bacterial infections.
Source: iScience
Language: English
Open Access status: gold
Estimated APC paid: $3,240
OpenAlex ID: W4416119009
FWCI: 0.468
Cites: 47
Cited by: 2
Related to: